OPPORTUNITY TO COLLABORATE

We welcome collaborations with our novel, selective 5-HT2B receptor antagonists to advance research in 5-HT2B receptor biology to further understand the use of 5-HT2B receptor antagonists. Companies with interest in fibrotic indications as well as companies focused on orphan indications are of particular interest.

For further information, please contact us.